OXB — Oxford BioMedica Share News
0.000.00%
Last trade - 00:00- £616.15m
- £699.51m
- £168.74m
Preliminary results for the year ended 31 Dec 2025
UK Stocks-Factors to watch on March 26
Europe Research Roundup: Endesa ,Cosmo Pharmaceuticals, Oxford Biomedica
Licensing agreement with VVMF
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
EQT backs out of takeover bid for UK's Oxford Biomedica (updated)
UK's Oxford Biomedica falls as takeover talks with EQT end
EQT backs out of takeover bid for UK's Oxford Biomedica
Brief: EQT Fund Management Says EQT Confirms No Intention To Make Offer For Oxford Biomedica
Brief: Oxford Biomedica Says Board Rejected EQT Proposals As Undervalued
Response to Rule 2.8 Announcement
Rule 2.8 Announcement
UK's Oxford Biomedica falls after keeping 2026 expectations unchanged
Brief: Oxford Biomedica Expects FY 2025 Revenues To Increase 30%
Brief: Oxford BioMedica Says EQT Must Announce Offer Intention By 25 February 2026
Extension of PUSU Deadline
UK's Oxford Biomedica rises after multi-year commercial supply deal with BMS
Brief: Oxford BioMedica Signs Multi-Year Supply Agreement With Bristol Myers Squibb